US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
オーストラリア
ASX
Paradigm Biopharmaceuticals Limited (PAROA) 銘柄情報

Paradigm Biopharmaceuticals Limited (PAROA)

0.001

0.00

( 0.00% )

更新日時： 09:00:00

Paradigm Biopharmaceuticals Limited (PAROA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.002

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 1,780,022

発行済株式数

428,519,176

配当利回り

PER

-1.38

1 株当たり利益 (EPS)

-0.1

歳入

8.45k

純利益

-36.09M

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya vir... Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.paradigmbiopharma.com

本社

Melbourne, Australia

設立

2026

Paradigm Biopharmaceuticals Limited is listed in the sector of the オーストラリア証券取引所 with ticker PAROA. The last closing price for Paradigm Biopharmaceutic... was AUD0. Over the last year, Paradigm Biopharmaceutic... shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Paradigm Biopharmaceutic... currently has 428,519,176 shares in issue. The market capitalisation of Paradigm Biopharmaceutic... is AUD428,519.18 . Paradigm Biopharmaceutic... has a price to earnings ratio (PE ratio) of -1.38.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

PAROA - Frequently Asked Questions (FAQ)

What is the current Paradigm Biopharmaceuticals Limited share price?

The current share price of Paradigm Biopharmaceuticals Limited is AUD 0.001

How many Paradigm Biopharmaceuticals Limited shares are in issue?

Paradigm Biopharmaceuticals Limited has 428,519,176 shares in issue

What is the market cap of Paradigm Biopharmaceuticals Limited?

The market capitalisation of Paradigm Biopharmaceuticals Limited is AUD 428.52k

What is the 1 year trading range for Paradigm Biopharmaceuticals Limited share price?

Paradigm Biopharmaceuticals Limited has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Paradigm Biopharmaceuticals Limited?

The price to earnings ratio of Paradigm Biopharmaceuticals Limited is -1.38

What is the cash to sales ratio of Paradigm Biopharmaceuticals Limited?

The cash to sales ratio of Paradigm Biopharmaceuticals Limited is 9.02k

What is the registered address of Paradigm Biopharmaceuticals Limited?

The registered address for Paradigm Biopharmaceuticals Limited is 500 Collins Street, Melbourne, Victoria, 3000

What is the Paradigm Biopharmaceuticals Limited website address?

The website address for Paradigm Biopharmaceuticals Limited is www.paradigmbiopharma.com

sometimes_right

sometimes_right 5分前

NEVERMIND, that weasel promoting click bait video titles now, busy like he accused mainstream media of doing. I thought it was good news, but upon rechecking the videos I now see it was published months ago originally. It didn't indicate that earlier today went I posted that video. My apologies

One11

Helter Skelter

Helter Skelter 8分前

I asked AI 🙃👉️ ROS 2 will sit on top of QNX and Nvidia THOR is that correct?

AI Overview 👉️ Yes, that is correct. ROS 2 is officially supported on the QNX real-time operating system (RTOS) and integrates closely with hardware compute platforms like Nvidia

zzNine2Five

zzNine2Five 8分前

IMHO, three major events are implicitly impacting the timeline of f2 relisting;
1. SpaceX needs to go IPO first, F2 later, go figure…
2. H.R. 6644 needs to be passed at senate.
3. The threshold of shares held by “ valued shareholders “ needs to be reached .
All other d

Kmacneill116

Kmacneill116 10分前

Cant hate on the hope homie!

Investor082

Investor082 11分前

You have been conditioned to come up with excuses and victim mindset by LP and her financiers + minions. Only losers complain. None of the other successful pre revenue biotechs complain.

SpaceX, Anthropic, and OpenAI IPOs are coming this summer. I expect some savvy folks to salvage w

joe botts

joe botts 11分前

TexasMarvL

TexasMarvL 15分前

Antimony has become a bigger part of the Reefton Auld Creek project.

https://youtu.be/LUaUgy0RAf0?is=JpmpqGgLrGgygDBz

LOB

Probably a good buy at .0004 if those assets are 152M not just 120M as someone else said. I remember when they were listed in the 220-250 range a couple years ago. Earnings should be out in 4-5 weeks on their usual extension.

jobynimble

jobynimble 21分前

Take a look at VMHG, setting up for explosive growth…

From the May 27 press release…

What to Watch Next
Investors may monitor:

Expansion of retail distribution footprint
Functional water production launch in June 2026
Revenue updates

eeprincipal

eeprincipal 22分前

US Market News

US Market News 22分前

Enliven Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded WarrantsJune 11, 2026 10:39 PM
PR Newswire (US) class="legendSpanClass"BURLINGAME, Calif., class="legendSpanClass"June 11, 2026 /PRNewswire/

Riley4

Riley4 22分前

I’m not selling but have now realized maybe big loss, for me anyway, small potatoes to many but big for me. Conclusion nefarious forces against this company. No other reason for this long wait for approval. Sad, as great tx. Will check price maybe first of q month but otherwise most my attention on

AhhWilderness

AhhWilderness 23分前

Greg Halpern re-emerges: https://www.youtube.com/watch?v=eL_a1dqRJ9o

uber darthium

uber darthium 23分前

This scam does not own a Trade Mark “TM” that it is claiming on “Fusion Engine”

That was grabbed by someone else years ago

Does Nelson and Hymen not realize that I am going to check every single word they ever publish ? Freakin con artists

What a patheti

jobynimble

jobynimble 24分前

Good timing with Spacex going public, Spacex and VMHG to da moon!!

Strap in for the ride haha…

Mozy429

Mozy429 25分前

Does anyone know for sure what happened with Purdue today? I saw the earlier comments but want to know if we won for sure or was that just rumors

WATERFALL1

WATERFALL1 28分前

Great Daily Chart on today

Some indicators have Golden Cross Stochastic Daily, Stochastic Momentum Index etc

VWAP looks Great

DredLock

DredLock 29分前

Yes, Lol. No bid for you!

HGiLS

Eliquis, oxycontin, pipeline, new contracts add up and increase the company valuation for M&a purposes

MasterBlastr

MasterBlastr 32分前

SPCX is gonna suck the life out of this one tomorrow.

joe botts

joe botts 34分前

Oh thats why they kept sending me to different departments through the company?

okwife

okwife 35分前

THEY WILL PROBABLY REV THIS BACK UP AGAIN

okwife

okwife 35分前

THEY WILL PROBABLY REV THIS BACK UP AGAIN

Paradigm Biopharmaceutic...

BEC World Public (EM)

Hargreaves Services

Liberty Funding Pty Ltd ...

Tanga Resources

DJ US Health Care Provid...

Procure Space ETF

Yieldmax Short Tsla Opti...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。